Resistance to apoptosis, increased growth potential, and altered gene expression in cells that survived genotoxic hexavalent chromium [Cr(VI)] exposure

Molecular and Cellular Biochemistry

Volumn 279, Issue 1-2, 2005, Pages 169-181

  Pritchard, Daryl E ^a   Ceryak, Susan ^a   Ramsey, Keri E ^b   O'Brien, Travis J ^a   Ha, Linan ^a   Fornsaglio, Jamie L ^a   Stephan, Dietrich A ^b   Patierno, Steven R ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^b TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; CHROMIUM; PROTEIN P53; TELOMERASE;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL ADHESION; CELL CULTURE; CELL CYCLE; CELL DEATH; CELL SELECTION; CELL SURVIVAL; CLONOGENESIS; CLUSTER ANALYSIS; DNA MICROARRAY; DNA REPAIR; FIBROBLAST; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC TRANSFECTION; GENOTOXICITY; HUMAN; HUMAN CELL; SIGNAL TRANSDUCTION; STRESS; TRANSCRIPTION REGULATION; TUMOR GROWTH;

APOPTOSIS; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CHROMATES; CHROMIUM; COLONY-FORMING UNITS ASSAY; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MUTAGENS; SODIUM COMPOUNDS; TELOMERASE; TIME FACTORS; TRANSFECTION;

EID: 30344485968     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-005-8292-2     Document Type: Article

References (87)

1. Hartwell LH, Kastan MB: Cell cycle control and cancer. Science 266: 1821-1828, 1994 7997877
2. Evan GI, Vousden KH: Proliferation, cell cycle and apoptosis in cancer. Nature 411: 342-348, 2001 10.1038/35077213
3. Blankenship LJ, Carlisle DL, Wise JP, Orenstein JM, Dye LE III, Patierno SR: Induction of apoptotic cell death by particulate lead chromate: differential effects of vitamins C and E on genotoxicity and survival. Toxicol Appl Pharmacol 146: 270-280, 1997 10.1006/taap.1997.8237
4. Carlisle DL, Pritchard DE, Singh J, Patierno SR: Chromium(VI) induces p53-dependent apoptosis in diploid human lung and mouse dermal fibroblasts. Mol Carcinog 28: 111-118, 2000 10900468
5. Carlisle DL, Pritchard DE, Singh J, Owens BM, Blankenship LJ, Orenstein JM, Patierno SR: Apoptosis and P53 induction in human lung fibroblasts exposed to chromium (VI): Effect of ascorbate and tocopherol. Toxicol Sci 55: 60-68, 2000 10.1093/toxsci/55.1.60
6. Singh J, Carlisle DL, Pritchard DE, Patierno SR: Chromium-induced genotoxicity and apoptosis: Relationship to chromium carcinogenesis (review). Oncol Rep 5: 1307-1318, 1998 9769362
7. Pritchard DE, Ceryak S, Ha L, Fornsaglio JL, Hartman SK, O'Brien TJ, Patierno SR: Mechanism of apoptosis and determination of cellular fate in chromium(VI)-exposed populations of telomerase-immortalized human fibroblasts. Cell Growth Differ 12: 487-496, 2001 11682460
8. Chromium, nickel and welding [erratum appears in IARC Monogr Eval Carcinog Risks Hum 1991; 51: 483]. IARC Monogr Eval Carcinog Risks Hum 49: 1-648, 1990
9. Hayes RB: Review of occupational epidemiology of chromium chemicals and respiratory cancer. Sci Total Environ 71: 331-339, 1988 10.1016/ 0048-9697(88)90205-7
10. Fishbein L: Sources, transport and alterations ofAmetal compounds: an overview. I. Arsenic, beryllium, cadmium, chromium, and nickel. Environ Health Perspect 40: 43-64, 1981 7023934
11. The chromium problem: Research needs and risk assessment. Environ Health Perspect 92: 1991
12. IARC: Monographs on the evaluation of the carcinogenic risk of chemicals to humans. 167-170, 1982
13. Burke DJ: Complexity in the spindle checkpoint. Curr Opin Genet Dev 10: 26-31, 2000 10.1016/S0959-437X(99)00040-4
14. Wetterhahn KE, Hamilton JW, Aiyar J, Borges KM, Floyd R: Mechanism of chromium(VI) carcinogenesis. Reactive intermediates and effect on gene expression. Biol Trace Element Res 21: 405-411, 1989
15. Rossi SC, Wetterhahn KE: Chromium(V) is produced upon reduction of chromate by mitochondrial electron transport chain complexes. Carcinogenesis 10: 913-920, 1989 2539917
16. Stearns DM, Wetterhahn KE: Reaction of chromium(VI) with ascorbate produces chromium(V), chromium(IV), and carbon-based radicals. Chem Res Toxicol 7: 219-230, 1994 10.1021/tx00038a016
17. Sugden KD, Martin BD: Guanine and 7,8-dihydro-8-oxo-guanine-specific oxidation in DNA by chromium(V). Environ Health Perspect 110(Suppl 5): 725-728, 2002 12426120
18. Sugden KD, Campo CK, Martin BD: Direct oxidation of guanine and 7,8-dihydro-8-oxoguanine in DNA by a high-valent chromium complex: A possible mechanism for chromate genotoxicity. Chem Res Toxicol 14: 1315-1322, 2001 10.1021/tx010088+
19. Miller CA III, Costa M: Characterization of DNA-protein complexes induced in intact cells by the carcinogen chromate. Mol Carcinog 1: 125-133, 1988 3151260
20. Standeven AM, Wetterhahn KE: Chromium (VI) toxicity: Uptake, reduction, and DNA damage. J Am Cell Toxicol 8: 1275-1283, 1989
21. Singh J, Mclean JA, Pritchard DE, Montaser A, Patierno SR: Sensitive quantitation of chromium-DNA adducts by inductively coupled plasma mass spectrometry with a direct injection high-efficiency nebulizer. Toxicol Sci 46: 260-265, 1998 10.1006/toxs.1998.2512
22. Xu J, Manning FC, Patierno SR: Preferential formation and repair of chromium-induced DNA adducts and DNA-protein crosslinks in nuclear matrix DNA. Carcinogenesis 15: 1443-1450, 1994 8033323
23. Xu J, Bubley GJ, Detrick B, Blankenship LJ, Patierno SR: Chromium(VI) treatment of normal human lung cells results in guanine-specific DNA polymerase arrest, DNA-DNA cross-links and S-phase blockade of cell cycle. Carcinogenesis 17: 1511-1517, 1996 8706257
24. Singh J, Bridgewater LC, Patierno SR: Differential sensitivity of chromium-mediated DNA interstrand crosslinks and DNA-protein crosslinks to disruption by alkali and EDTA. Toxicol Sci 45: 72-76, 1998 10.1006/ toxs.1998.2489
25. Bridgewater LC, Manning FC, Patierno SR: Base-specific arrest of in vitro DNA replication by carcinogenic chromium: Relationship to DNA interstrand crosslinking. Carcinogenesis 15: 2421-2427, 1994 7955085
26. O'Brien TJ, Ceryak S, Patierno SR: Complexities of chromium carcinogenesis: Role of cellular response, repair and recovery mechanisms. Mutat Res 533: 3-36, 2003 14643411
27. Bridgewater LC, Manning FC, Woo ES, Patierno SR: DNA polymerase arrest by adducted trivalent chromium. Mol Carcinog 9: 122-133, 1994 8142016
28. Manning FC, Xu J, Patierno SR: Transcriptional inhibition by carcinogenic chromate: Relationship to DNA damage. Mol Carcinog 6: 270-279, 1992 1283064
29. Patierno SR, Banh D, Landolph JR: Transformation of C3H/10T1/2 mouse embryo cells to focus formation and anchorage independence by insoluble lead chromate but not soluble calcium chromate: Relationship to mutagenesis and internalization of lead chromate particles. Cancer Res 48: 5280-5288, 1988 3409252
30. Patierno SR, Landolph JR: Soluble vs insoluble hexavalent chromate. Relationship of mutation to in vitro transformation and particle uptake. Biol Trace Element Res 21: 469-474, 1989
31. Zhitkovich A, Song Y, Quievryn G, Voitkun V: Non-oxidative mechanisms are responsible for the induction of mutagenesis by reduction of Cr(VI) with cysteine: Role of ternary DNA adducts in Cr(III)-dependent mutagenesis. Biochemistry 40: 549-560, 2001 10.1021/bi0015459
32. Tully DB, Collins BJ, Overstreet JD, Smith CS, Dinse GE, Mumtaz MM, Chapin RE: Effects of arsenic, cadmium, chromium, and lead on gene expression regulated by a battery of 13 different promoters in recombinant HepG2 cells. Toxicol Appl Pharmacol 168: 79-90, 2000 10.1006/ taap.2000.9014
33. Wetterhahn KE, Hamilton JW: Molecular basis of hexavalent chromium carcinogenicity: Effect on gene expression. Sci Total Environ 86: 113-129, 1989 10.1016/0048-9697(89)90199-X
34. Hamilton JW, Kaltreider RC, Bajenova OV, Ihnat MA, McCaffrey J, Turpie BW, Rowell EE, Oh J, Nemeth MJ, Pesce CA, Lariviere JP: Molecular basis for effects of carcinogenic heavy metals on inducible gene expression. Environ Health Perspect 106(Suppl 4): 1005-1015, 1998 9703486
35. Wise JP, Orenstein JM, Patierno SR: Inhibition of lead chromate clastogenesis by ascorbate: Relationship to particle dissolution and uptake. Carcinogenesis 14: 429-434, 1993 8453719
36. Wise JP Sr, Stearns DM, Wetterhahn KE, Patierno SR: Cell-enhanced dissolution of carcinogenic lead chromate particles: The role of individual dissolution products in clastogenesis. Carcinogenesis 15: 2249-2254, 1994 7955062
37. Wright WE, Pereira-Smith OM, Shay JW: Reversible cellular senescence: implications for immortalization of normal human diploid fibroblasts. Mol Cell Biol 9: 3088-3092, 1989 2779554
38. Campisi J: ReplicaAive senescence: an old lives' tale? Cell 84: 497-500, 1996
39. Shay JW, Pereira-Smith OM, Wright WE: A role for both RB and p53 in the regulation of human cellular senescence. Exp Cell Res 196: 33-39, 1991 10.1016/0014-4827(91)90453-2
40. Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB, Bacchetti S: Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 11: 1921-1929, 1992 1582420
41. Jiang XR, Jimenez G, Chang E, Frolkis M, Kusler B, Sage M, Beeche M, Bodnar AG, Wahl GM, Tlsty TD, Chiu CP: Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nat Genet 21: 111-114, 1999 10.1038/5056
42. Vaziri H, Squire JA, Pandita TK, Bradley G, Kuba RM, Zhang H, Gulyas S, Hill RP, Nolan GP, Benchimol S: Analysis of genomic integrity and p53-dependent G1 checkpoint in telomerase-induced extended-life-span human fibroblasts. Mol Cell Biol 19: 2373-2379, 1999 10022923
43. Ha L, Ceryak S, Patierno SR: Chromium (VI) activates ataxia telangiectasia mutated (ATM) protein: Requirement of ATM for both apoptosis and recovery from terminal growth arrest. J Biol Chem 278: 17885-17894, 2003 12637545
44. Chen YW, Zhao P, Borup R, Hoffman EP: Expression profiling in the muscular dystrophies: Identification of novel aspects of molecular pathophysiology. J Cell Biol 151: 1321-1336, 2000 10.1083/jcb.151.6.1321
45. Ye J, Wang S, Leonard SS, Sun Y, Butterworth L, Antonini J, Ding M, Rojanasakul Y, Vallyathan V, Castranova V, Shi X: Role of reactive oxygen species and p53 in chromium(VI)-induced apoptosis. J Biol Chem 274: 34974-34980, 1999 10.1074/jbc.274.49.34974
46. Igney FH, Krammer PH: Death and anti-death: Tumour resistance to apoptosis. Nat Rev Cancer 2: 277-288, 2002 10.1038/nrc776
47. Hofseth LJ: The adaptive imbalance to Genotoxic stress: genome guardians rear their ugly heads. Carcinogenesis 25: 1787-1793, 2004 10.1093/carcin/ bgh196
48. Flatt PM, Polyak K, Tang LJ, Scatena CD, Westfall MD, Rubinstein LA, Yu J, Kinzler KW, Vogelstein B, Hill DE, Pietenpol JA: P53-dependent expression of PIG3 during proliferation, genotoxic stress, and reversible growth arrest. Cancer Lett 156: 63-72, 2000 10.1016/ S0304-3835(00)00441-9
49. Levine AJ: P53, the cellular gatekeeper for growRh and division: review [55 refs]. Cell 88: 323-331, 1997 10.1016/S0092-8674(00)81871-1
50. Son KH, Zhang M, Rucobo E, Nwaigwe D, Montgomery F, Leffert H: Derivation and study of human epithelial cell lines resistant to killing by chromium trioxide. J Toxicol Environ Health A 67: 1027-1049, 2004 10.1080/15287390490447304
51. Tamas MJ, Wysocki R: Mechanisms involved in metalloid transport and tolerance acquisition. Curr Genet 40: 2-12, 2001 10.1007/s002940100234
52. Wernyj RP, Morin PJ: Molecular mechanisms of platinum resistance: Still searching for the Achilles' heel. Drug Resist Updat 7: 227-232, 2004 10.1016/j.drup.2004.08.002
53. Ye J, Shi X: Gene expression profile in response to chromium-induced cell stress in A549 cells. Mol Cell Biochem 222: 189-197, 2001 10.1023/ A:1017974415052
54. Izzotti A, Cartiglia C, Balansky R, D'Agostini F, Longobardi M, De Flora S: Selective induction of gene expression in rat lung by hexavalent chromium. Mol Carcinog 35: 75-84, 2002 10.1002/mc.10077
55. D'Agostini F, Izzotti A, Bennicelli C, Camoirano A, Tampa E, De Flora S: Induction of apoptosis in the lung but not in the liver of rats receiving intra-tracheal instillations of chromium(VI). Carcinogenesis 23: 587-593, 2002 10.1093/carcin/23.4.587
56. Andrew AS, Warren AJ, Barchowsky A, Temple KA, Klei L, Soucy NV, O'Hara KA, Hamilton JW: Genomic and proteomic profiling of responses to toxic metals in human lung cells. Environ Health Perspect 111: 825-835, 2003 12760830
57. Ceryak S, Zingariello C, O'Brien T, Patierno SR: Induction of pro-apoptotic and cell cycle-inhibiting genes in chromium(VI)-treated human lung fibroblasts: Lack of effect of ERK. Mol Cell Biochem 255: 139-149, 2004 10.1023/B:MCBI.0000007270.82431.3e
58. Thomas G: MAP kinase by any other name smells just as sweet. Cell 68: 3-6, 1992 10.1016/0092-8674(92)90199-M
59. Ballif BA, Blenis J: Molecular mechanisms mediating mammalian mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK cell survival signals. Cell Growth Differ 12: 397-408, 2001 11504705
60. Moelling K, Schad K, Bosse M, Zimmermann S, Schweneker M: Regulation of Raf-Akt Cross-talk. J Biol Chem 277: 31099-31106, 2002 10.1074/ jbc.M111974200
61. Murphy LO, Smith S, Chen RH, Fingar DC, Blenis J: Molecular interpretation of ERK signal duration by immediate early gene products. Nat Cell Biol 4: 556-564, 2002 12134156
62. Keyse SM: Protein phosphatases and the regulation of mitogen-activated protein kinase signalling: Review [49 refs]. Curr Opin Cell Biol 12: 186-192, 2000 10.1016/S0955-0674(99)00075-7
63. Zhou B, Wang ZX, Zhao Y, Brautigan DL, Zhang ZY: The specificity of extracellular signal-regulated kinase 2 dephosphorylation by protein phosphatases. J Biol Chem 277: 31818-31825, 2002 10.1074/jbc.M203969200
64. Theodosiou A, Smith A, Gillieron C, Arkinstall S, Ashworth A: MKP5, a new member of the MAP kinase phosphatase family, which selectively dephosphorylates stress-activated kinases. Oncogene 18: 6981-6988, 1999 10.1038/sj.onc.1203185
65. Samet JM, Graves LM, Quay J, Dailey LA, Devlin RB, Ghio AJ, Wu W, Bromberg PA, Reed W: Activation of MAPKs in human bronchial epithelial cells exposed to metals. Am J Physiol 275: L551-L558, 1998 9728050
66. Chuang SM, Liou GY, Yang JL: Activation of JNK, p38 and ERK mitogen-activated protein kinases by chromium(VI) is mediated through oxidative stress but does not affect cytotoxicity. Carcinogenesis 21: 1491-1500, 2000 10.1093/carcin/21.8.1491
67. Chuang SM, Yang JL: Comparison of roles of three mitogen-activated protein kinases induced by chromium(VI) and cadmium in non-small-cell lung carcinoma cells. Mol Cell Biochem 222: 85-95, 2001 10.1023/ A:1017967408266
68. Landolph JR: Molecular mechanisms of transformation of C3H/10T1/2 C1 8 mouse embryo cells and diploid human fibroblasts by carcinogenic metal compounds: Review [58 refs]. Environ Health Perspect 102(Suppl 3): 119-125, 1994
69. Gilmore TD, Kalaitzidis D, Liang MC, Starczynowski DT: The c-Rel transcription factor and B-cell proliferation: A deal with the devil. Oncogene 23: 2275-2286, 2004 10.1038/sj.onc.1207410
70. Hanson JL, Hawke NA, Kashatus D, Baldwin AS: The nuclear factor kappaB subunits RelA/p65 and c-Rel potentiate but are not required for Ras-induced cellular transformation. Cancer Res 64: 7248-7255, 2004 10.1158/0008-5472.CAN-03-3898
71. Shumilla JA, Wetterhahn KE, Barchowsky A: Inhibition of NF-kappa B binding to DNA by chromium, cadmium, mercury, zinc, and arsenite in vitro : Evidence of a thiol mechanism. Arch Biochem Biophys 349: 356-362, 1998 10.1006/abbi.1997.0470
72. Chen F, Bower J, Leonard SS, Ding M, Lu Y, Rojanasakul Y, Kung HF, Vallyathan V, Castranova V, Shi X: Protective roles of NF-kappa B for chromium(VI)-induced cytotoxicity is revealed by expression of Ikappa B kinase-beta mutant. J Biol Chem 277: 3342-3349, 2002 10.1074/ jbc.M101089200
73. Kaltreider RC, Pesce CA, Ihnat MA, Lariviere JP, Hamilton JW: Differential effects of arsenic(III) and chromium(VI) on nuclear transcription factor binding. Mol Carcinog 25: 219-229, 1999 10.1002/ (SICI)1098-2744(199907)25:3<219::AID-MC8>3.0.CO;2-X
74. Hahn WC, Weinberg RA: Modelling the molecular circuitry of cancer. Nat Rev Cancer 2: 331-341, 2002 10.1038/nrc795
75. Mathon NF, Lloyd AC: Cell senescence and cancer. Nat Rev Cancer 1: 203-213, 2001 10.1038/35106045
76. Lehmann AR: DNA repair-deficient diseases, xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy. Biochimie 85: 1101-1111, 2003 10.1016/j.biochi.2003.09.010
77. Rosselli F, Briot D, Pichierri P: The Fanconi anemia pathway and the DNA interstrand cross-links repair. Biochimie 85: 1175-1184, 2003 10.1016/ j.biochi.2003.11.002
78. Eastman QM, Villey IJ, Schatz DG: Detection of RAG protein-V(D)J recombination signal interactions near the site of DNA cleavage by UV cross-linking. Mol Cell Biol 19: 3788-3797, 1999 10207102
79. Mo X, Bailin T, Sadofsky MJ: RAG1 and RAG2 cooperate in specific binding to the recombination signal sequence in vitro. J Biol Chem 274: 7025-7031, 1999 10.1074/jbc.274.11.7025
80. Reynolds M, Peterson E, Quievryn G, Zhitkovich A: Human nucleotide excision repair efficiently removes chromium-DNA phosphate adducts and protects cells against chromate toxicity. J Biol Chem 279: 30419-30424, 2004 10.1074/jbc.M402486200
81. O'Brien TJ, Fornsaglio JL, Ceryak S, Patierno SR: Effects of hexavalent chromium on the survival and cell cycle distribution of DNA repair-deficient S. cerevisiae. DNA Repair 1: 617-627, 2002 10.1016/ S1568-7864(02)00078-2
82. Sheela S, Barrett JC: Degradation of type IV collagen by neoplastic human skin fibroblasts. Carcinogenesis 6: 173-179, 1985 2982512
83. Tsujimoto Y, Shimizu S: VDAC regulation by the Bcl-2 family of proteins: Review [73 refs]. Cell Death Differ 7: 1174-1181, 2000 10.1038/ sj.cdd.4400780
84. Vieira HL, Haouzi D, El Hamel C, Jacotot E, Belzacq AS, Brenner C, Kroemer G: Permeabilization of the mitochondrial inner membrane during apoptosis: Impact of the adenine nucleotide translocator. Cell Death Differ 7: 1146-1154, 2000 10.1038/sj.cdd.4400778
85. Halestrap AP, McStay GP, Clarke SJ: The permeability transition pore complex:RAnother view: review [86 refs]. Biochimie 84: 153-166, 2002 10.1016/S0300-9084(02)01375-5
86. Harris MH, Thompson CB: The role of the Bcl-2 family in the regulation of outer mitochondrial membrane permeability: Review [92 refs]. Cell Death Differ 7: 1182-1191, 2000 10.1038/sj.cdd.4400781
87. Pritchard DE, Singh J, Carlisle DL, Patierno SR: Cyclosporin A inhibits chromium(VI)-induced apoptosis and mitochondrial cytochrome c release and restores clonogenic survival in CHO cells. Carcinogenesis 21: 2027-2033, 2000 10.1093/carcin/21.11.2027